Protein name:
Collagen alpha-2(IV) chain ;
Alternative:
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
There are six type IV collagen isoforms, alpha 1(IV)-alpha 6(IV), each of which can form a triple helix structure with 2 other chains to generate type IV collagen network.
Function:
Canstatin, a cleavage product corresponding to the collagen alpha 2(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity. It inhibits proliferation and migration of endothelial cells, reduces mitochondrial membrane potential, and induces apoptosis. Specifically induces Fas-dependent apoptosis and activates procaspase-8 and -9 activity. Ligand for alphavbeta3 and alphavbeta5 integrins.
Subcellular Location:
Secreted
extracellular space
extracellular matrix
basement membrane
Protein Attributes:
50:
MGRDQRAVAG | PALRRWLLLG | TVTVGFLAQS | VLAGVKKFDV | PCGGRDCSGG |
100:
CQCYPEKGGR | GQPGPVGPQG | YNGPPGLQGF | PGLQGRKGDK | GERGAPGVTG |
150:
PKGDVGARGV | SGFPGADGIP | GHPGQGGPRG | RPGYDGCNGT | QGDSGPQGPP |
200:
GSEGFTGPPG | PQGPKGQKGE | PYALPKEERD | RYRGEPGEPG | LVGFQGPPGR |
250:
PGHVGQMGPV | GAPGRPGPPG | PPGPKGQQGN | RGLGFYGVKG | EKGDVGQPGP |
300:
NGIPSDTLHP | IIAPTGVTFH | PDQYKGEKGS | EGEPGIRGIS | LKGEEGIMGF |
350:
PGLRGYPGLS | GEKGSPGQKG | SRGLDGYQGP | DGPRGPKGEA | GDPGPPGLPA |
400:
YSPHPSLAKG | ARGDPGFPGA | QGEPGSQGEP | GDPGLPGPPG | LSIGDGDQRR |
450:
GLPGEMGPKG | FIGDPGIPAL | YGGPPGPDGK | RGPPGPPGLP | GPPGPDGFLF |
500:
GLKGAKGRAG | FPGLPGSPGA | RGPKGWKGDA | GECRCTEGDE | AIKGLPGLPG |
550:
PKGFAGINGE | PGRKGDRGDP | GQHGLPGFPG | LKGVPGNIGA | PGPKGAKGDS |
600:
RTITTKGERG | QPGVPGVPGM | KGDDGSPGRD | GLDGFPGLPG | PPGDGIKGPP |
650:
GDPGYPGIPG | TKGTPGEMGP | PGLGLPGLKG | QRGFPGDAGL | PGPPGFLGPP |
700:
GPAGTPGQID | CDTDVKRAVG | GDRQEAIQPG | CIGGPKGLPG | LPGPPGPTGA |
750:
KGLRGIPGFA | GADGGPGPRG | LPGDAGREGF | PGPPGFIGPR | GSKGAVGLPG |
800:
PDGSPGPIGL | PGPDGPPGER | GLPGEVLGAQ | PGPRGDAGVP | GQPGLKGLPG |
850:
DRGPPGFRGS | QGMPGMPGLK | GQPGLPGPSG | QPGLYGPPGL | HGFPGAPGQE |
900:
GPLGLPGIPG | REGLPGDRGD | PGDTGAPGPV | GMKGLSGDRG | DAGFTGEQGH |
950:
PGSPGFKGID | GMPGTPGLKG | DRGSPGMDGF | QGMPGLKGRP | GFPGSKGEAG |
1000:
FFGIPGLKGL | AGEPGFKGSR | GDPGPPGPPP | VILPGMKDIK | GEKGDEGPMG |
1050:
LKGYLGAKGI | QGMPGIPGLS | GIPGLPGRPG | HIKGVKGDIG | VPGIPGLPGF |
1100:
PGVAGPPGIT | GFPGFIGSRG | DKGAPGRAGL | YGEIGATGDF | GDIGDTINLP |
1150:
GRPGLKGERG | TTGIPGLKGF | FGEKGTEGDI | GFPGITGVTG | VQGPPGLKGQ |
1200:
TGFPGLTGPP | GSQGELGRIG | LPGGKGDDGW | PGAPGLPGFP | GLRGIRGLHG |
1250:
LPGTKGFPGS | PGSDIHGDPG | FPGPPGERGD | PGEANTLPGP | VGVPGQKGDQ |
1300:
GAPGERGPPG | SPGLQGFPGI | TPPSNISGAP | GDKGAPGIFG | LKGYRGPPGP |
1350:
PGSAALPGSK | GDTGNPGAPG | TPGTKGWAGD | SGPQGRPGVF | GLPGEKGPRG |
1400:
EQGFMGNTGP | TGAVGDRGPK | GPKGDPGFPG | APGTVGAPGI | AGIPQKIAVQ |
1450:
PGTVGPQGRR | GPPGAPGEMG | PQGPPGEPGF | RGAPGKAGPQ | GRGGVSAVPG |
1500:
FRGDEGPIGH | QGPIGQEGAP | GRPGSPGLPG | MPGRSVSIGY | LLVKHSQTDQ |
1550:
EPMCPVGMNK | LWSGYSLLYF | EGQEKAHNQD | LGLAGSCLAR | FSTMPFLYCN |
1600:
PGDVCYYASR | NDKSYWLSTT | APLPMMPVAE | DEIKPYISRC | SVCEAPAIAI |
1650:
AVHSQDVSIP | HCPAGWRSLW | IGYSFLMHTA | AGDEGGGQSL | VSPGSCLEDF |
1700:
RATPFIECNG | GRGTCHYYAN | KYSFWLTTIP | EQSFQGSPSA | DTLKAGLIRT |
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Bovine
Mouse
ELISA Kit for Human Collagen alpha-2(IV) chain
ELISA Kit for Human Collagen alpha-2(IV) chain
ELISA Kit for Human Collagen alpha-2(IV) chain
CLIA Kit for Human Collagen alpha-2(IV) chain
CLIA Kit for Human Collagen alpha-2(IV) chain
CLIA Kit for Human Collagen alpha-2(IV) chain
Polyclonal Antibody for Human Collagen alpha-2(IV) chain
Polyclonal Antibody for Human Collagen alpha-2(IV) chain
Polyclonal Antibody for Human Collagen alpha-2(IV) chain
Monoclonal Antibody for Human Collagen alpha-2(IV) chain
Monoclonal Antibody for Human Collagen alpha-2(IV) chain
Monoclonal Antibody for Human Collagen alpha-2(IV) chain
Protein for Human Collagen alpha-2(IV) chain
Protein for Human Collagen alpha-2(IV) chain
Protein for Human Collagen alpha-2(IV) chain
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA]
2.
"The DNA sequence and analysis of human chromosome 13."
Dunham A.
,
Matthews L.H.
,
Burton J.
,
Ashurst J.L.
,
Howe K.L.
,
Ashcroft K.J.
,
Beare D.M.
,
Burford D.C.
,
Hunt S.E.
,
Griffiths-Jones S.
,
Jones M.C.
,
Keenan S.J.
,
Oliver K.
,
Scott C.E.
,
Ainscough R.
,
Almeida J.P.
,
Ambrose K.D.
,
Andrews D.T.
,
Ashwell R.I.S.
,
Babbage A.K.
,
Bagguley C.L.
,
Bailey J.
,
Bannerjee R.
,
Barlow K.F.
,
Bates K.
,
Beasley H.
,
Bird C.P.
,
Bray-Allen S.
,
Brown A.J.
,
Brown J.Y.
,
Burrill W.
,
Carder C.
,
Carter N.P.
,
Chapman J.C.
,
Clamp M.E.
,
Clark S.Y.
,
Clarke G.
,
Clee C.M.
,
Clegg S.C.
,
Cobley V.
,
Collins J.E.
,
Corby N.
,
Coville G.J.
,
Deloukas P.
,
Dhami P.
,
Dunham I.
,
Dunn M.
,
Earthrowl M.E.
,
Ellington A.G.
,
Faulkner L.
,
Frankish A.G.
,
Frankland J.
,
French L.
,
Garner P.
,
Garnett J.
,
Gilbert J.G.R.
,
Gilson C.J.
,
Ghori J.
,
Grafham D.V.
,
Gribble S.M.
,
Griffiths C.
,
Hall R.E.
,
Hammond S.
,
Harley J.L.
,
Hart E.A.
,
Heath P.D.
,
Howden P.J.
,
Huckle E.J.
,
Hunt P.J.
,
Hunt A.R.
,
Johnson C.
,
Johnson D.
,
Kay M.
,
Kimberley A.M.
,
King A.
,
Laird G.K.
,
Langford C.J.
,
Lawlor S.
,
Leongamornlert D.A.
,
Lloyd D.M.
,
Lloyd C.
,
Loveland J.E.
,
Lovell J.
,
Martin S.
,
Mashreghi-Mohammadi M.
,
McLaren S.J.
,
McMurray A.
,
Milne S.
,
Moore M.J.F.
,
Nickerson T.
,
Palmer S.A.
,
Pearce A.V.
,
Peck A.I.
,
Pelan S.
,
Phillimore B.
,
Porter K.M.
,
Rice C.M.
,
Searle S.
,
Sehra H.K.
,
Shownkeen R.
,
Skuce C.D.
,
Smith M.
,
Steward C.A.
,
Sycamore N.
,
Tester J.
,
Thomas D.W.
,
Tracey A.
,
Tromans A.
,
Tubby B.
,
Wall M.
,
Wallis J.M.
,
West A.P.
,
Whitehead S.L.
,
Willey D.L.
,
Wilming L.
,
Wray P.W.
,
Wright M.W.
,
Young L.
,
Coulson A.
,
Durbin R.M.
,
Hubbard T.
,
Sulston J.E.
,
Beck S.
,
Bentley D.R.
,
Rogers J.
,
Ross M.T.
more...
Nature428:522-528(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1-1042;VARIANTS LYS-517 AND ALA-683
tissue :
Placenta .
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33
5.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33
6.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33
tissue :
Skin .
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1040-1712
tissue :
Placenta .
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1254-1712;VARIANT ILE-1399
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1351-1712
tissue :
Eye .
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1451-1485
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : PROTEIN SEQUENCE OF 1480-1535; 1545-1614; 1617-1701 AND 1705-1712
tissue :
Placenta .
12.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712
13.
"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth."
Kamphaus G.D.
,
Colorado P.C.
,
Panka D.J.
,
Hopfer H.
,
Ramchandran R.
,
Torre A.
,
Maeshima Y.
,
Mier J.W.
,
Sukhatme V.P.
,
Kalluri R.
J. Biol. Chem.275:1209-1215(2000)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712;FUNCTION
14.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712
15.
"Molecular cloning and homologous sequence analysis of canstatin cDNA derived from Chinese hepatocytes."
Li Y.
,
Huang G.
,
Qian G.
Submitted (2003-10) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712
tissue :
Hepatocyte .
16.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 1486-1712
17.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION OF CANSTATIN
18.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION OF CANSTATIN
19.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
20.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1485-1712
21.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS PHE-192; LYS-517; ALA-683; ARG-701 AND SER-718
22.
"De novo and inherited mutations in COL4A2, encoding the type IV collagen alpha2 chain cause porencephaly."
Yoneda Y.
,
Haginoya K.
,
Arai H.
,
Yamaoka S.
,
Tsurusaki Y.
,
Doi H.
,
Miyake N.
,
Yokochi K.
,
Osaka H.
,
Kato M.
,
Matsumoto N.
,
Saitsu H.
Am. J. Hum. Genet.90:86-90(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS POREN2 GLU-1037 AND ASP-1152
23.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INVOLVEMENT IN SUSCEPTIBILITY TO ICH;VARIANTS PHE-192; LYS-517; ALA-683; ARG-701; SER-718; GLN-1109; GLY-1123; LYS-1150; ILE-1399 AND THR-1690;CHARACTERIZATION OF VARIANTS GLY-1123; LYS-1150 AND THR-1690
24.
"COL4A2 mutation associated with familial porencephaly and small-vessel disease."
Verbeek E.
,
Meuwissen M.E.
,
Verheijen F.W.
,
Govaert P.P.
,
Licht D.J.
,
Kuo D.S.
,
Poulton C.J.
,
Schot R.
,
Lequin M.H.
,
Dudink J.
,
Halley D.J.
,
de Coo R.I.
,
den Hollander J.C.
,
Oegema R.
,
Gould D.B.
,
Mancini G.M.
Eur. J. Hum. Genet.20:844-851(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT ARG-1389